Introduction

I. Evaluation of Chronic Inflammatory bowel disease (IBD).

II. IBD is a health condition that leads to digestive tract inflammation (Khan, Ullah, Zha, Bai, Khan, Zhao & Zhang, 2019).

III. Fatigue, diarrhea, and abdominal pain are major IBD symptoms.

IV. The role of nutrition in preventing and treating IBD.

The role of nutrition in the prevention of IBD.

I. The role of nutrition in eradicating IBD.

II. The risk diets that promote IBD include food with low fiber and high fat.

III. Nutritional supplements such as omega-3 fatty acids and probiotics reduce the chances of IBD.

Etiology

I. The risk factors associated with IBD; namely.

II. Environmental factors include viral infections and diet, genetic factors, Ethnicity, young age, and smoking (Taft et al., 2019).

Progressive

I. Complications: Anemia, malnutrition, and dehydration

II. Symptoms: fatigue, diarrhea, and abdominal pain

III. Pathogenesis: normal bacterial flora in the gut and abdominal immune response

Treatment

I. Antibiotics

II. Immune systems modulators (Jakubczyk, Leszczy?ska & Górska, 2020).

III. Anti-inflammatory drugs

IV. Surgery is necessary in some cases.

Recommendations

I. Recommendations regarding the prevention of the disease.

II. People must consume a high-fiber diet to avoid IBD.

III. People must avoid eating small, frequent, and processed foods is essential.

IV. Nutrition therapy.

V. Other medical recommendations include the consumption of omega-3 fatty acids, probiotics, and nutritional supplements.

Nursing assessment

I. Laboratory and imaging tests, physical assessment, and health history.

II. Lifestyle, diet, family history, and questions about symptoms.

III. The physical assessment involves laboratory tests, blood tests, and stool samples. This part will also examine abdominal pain (Pithadia & Jain, 2011).

IV. The imaging test is critical since it will evaluate diagnoses of IBD.

Nursing interventions

I. Non-pharmacological and pharmacological (Mumolo et al., 2018).

II. Pharmacological interventions: immune system modulators and anti-inflammatory drugs

III. Non-pharmacology: exercise, diet, and intervention of lifestyle.

Client Education and adherence

I. Self-management strategies, lifestyle changes, and taking medications.

II. Importance of adherence to prescribed medication and follow-ups.

Conclusion

I. Summary of what IBD is, the role of dietary in preventing IBD, and treatment.

II. Symptoms that call for medication early enough before major complications.

Reference

Jakubczyk, D., Leszczy?ska, K., & Górska, S. (2020). The effectiveness of probiotics in treating inflammatory bowel disease (IBD)—a critical review. Nutrients, 12(7), 1973.

Khan, I., Ullah, N., Zha, L., Bai, Y., Khan, A., Zhao, T., … & Zhang, C. (2019). Alteration of gut microbiota in inflammatory bowel disease (IBD): cause or consequence? IBD treatment targeting the gut microbiome. Pathogens, 8(3), 126.

Mumolo, M. G., Bertani, L., Ceccarelli, L., Laino, G., Di Fluri, G., Albano, E., … & Costa, F. (2018). From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting. World Journal of Gastroenterology, 24(33), 3681.

Pithadia, A. B., & Jain, S. (2011). Treatment of inflammatory bowel disease (IBD). Pharmacological Reports, 63(3), 629–642.

Taft, T. H., Bedell, A., Craven, M. R., Guadagnoli, L., Quinton, S., & Hanauer, S. B. (2019). Initial assessment of post-traumatic stress in a US cohort of inflammatory bowel disease patients. Inflammatory bowel diseases, 25(9), 1577-1585.